BIO Statement on Medicare Part D Data ReleaseMay 1 2015
BIO supports transparency in sharing data in the life sciences industry so that patients and physicians can make treatment decisions based on accurate, timely, and easily accessible information. However...
|
|
2015 BIO International Convention Buzz of BIO Winners AnnouncedApr 30 2015
Buzz of BIO Competition Recognizes Highly Innovative Biotech Companies
|
|
Biotech Leader Provides Testimony on Legislative Proposals to Enhance Capital Formation and Reduce Regulatory BurdensApr 30 2015
Enhancing the capital formation ecosystem will help expedite the next generation of breakthrough medicines
|
|
Statement Regarding the Introduction of Senate Patent Reform LegislationApr 29 2015
We note with disappointment that the bill introduced today does not contain any of the critically needed reforms to prevent the continued exploitation and abuse of the PTO’s inter partes review (IPR) proceeding against patent owners.
|
|
BIO Praises the Release of 21st Century Cures Initiative Discussion DraftApr 29 2015
Washington, D.C. (April 29, 2015) – The Biotechnology Industry Organization (BIO) today releases the following statement on the 21st Century Cures Initiative discussion draft shared by Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Rep. Frank Pallone, Jr. (D-NJ), Rep. Joe Pitts (R-PA), and Rep. Gene Green (D-TX).
|
|
BIO Welcomes GM Product Approvals but Opposes EU Move to Undermine International ObligationsApr 24 2015
The Biotechnology Industry Organization (BIO) welcomes the European Commission’s decision to approve seventeen genetically modified (GM) food and feed products that have been long delayed by political interference, some of which received a positive European scientific opinion as far back as November 2013.
|
|
BIO Welcomes GM Product Approvals but Opposes EU Move to Undermine International ObligationsApr 24 2015
The Biotechnology Industry Organization (BIO) welcomes the European Commission’s decision to approve seventeen genetically modified (GM) food and feed products that have been long delayed by political interference, some of which received a positive European scientific opinion as far back as November 2013.
However, news of the approvals is greatly overshadowed by the EU proposal for legislation to break from the single market and its World Trade Organization (WTO) commitments by enabling individual member states to ignore scientific consensus and block the use of imported GM products at the national level.
|
|
BIO Thanks Senators for Urging EPA to Set Strong 2014 RFS RequirementsApr 23 2015
Today 37 Senators wrote EPA Administrator Gina McCarthy urging the agency to set strong biofuel volume requirements for 2014 and beyond that are consistent with the Renewable Fuel Standard (RFS).
|
|
Philadelphia Mayor Michael Nutter Issues Proclamation for BIO Superhero Day, Monday, June 15Apr 23 2015
Joint press conference between Mayor Nutter, BIO, the Philadelphia CVB and Pennsylvania BIO highlights BIO 2015
|
|
BIO Praises Rep. Robert Hurt for Introducing the Small Company Disclosure Simplification ActApr 22 2015
We would like to thank Rep. Hurt for introducing this legislation to minimize the costly regulatory burden of XBRL, which can delay scientific progress and slow the growth of promising emerging biotech companies.
|
